MedPath

Fluticasone Propionate

These highlights do not include all the information needed to use Fluticasone Propionate Nasal Spray, USP safely and effectively. See full prescribing information for Fluticasone Propionate Nasal Spray, USP.Fluticasone Propionate nasal spray, USP, 50 mcgFOR INTRANASAL USEInitial U.S. Approval: 1994

Approved
Approval ID

532c9b61-9e3f-461b-87c9-9d6b71f6d2e2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 15, 2021

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluticasone Propionate

PRODUCT DETAILS

NDC Product Code50090-2484
Application NumberANDA077570
Marketing CategoryC73584
Route of AdministrationNASAL
Effective DateOctober 9, 2020
Generic NameFluticasone Propionate

INGREDIENTS (8)

DEXTROSE, UNSPECIFIED FORMInactive
Code: IY9XDZ35W2
Classification: IACT
PHENYLETHYL ALCOHOLInactive
Code: ML9LGA7468
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
FLUTICASONE PROPIONATEActive
Quantity: 50 ug in 0.1 g
Code: O2GMZ0LF5W
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMInactive
Code: K679OBS311
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.